Estimating the effects of non-pharmaceutical interventions on the number of new infections with COVID-19 during the first epidemic wave

The novel coronavirus (SARS-CoV-2) has rapidly developed into a global epidemic. To control its spread, countries have implemented non-pharmaceutical interventions (NPIs), such as school closures, bans of small gatherings, or even stay-at-home orders. Here we study the effectiveness of seven NPIs in...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 16; no. 6; p. e0252827
Main Authors Banholzer, Nicolas, van Weenen, Eva, Lison, Adrian, Cenedese, Alberto, Seeliger, Arne, Kratzwald, Bernhard, Tschernutter, Daniel, Salles, Joan Puig, Bottrighi, Pierluigi, Lehtinen, Sonja, Feuerriegel, Stefan, Vach, Werner
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 02.06.2021
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The novel coronavirus (SARS-CoV-2) has rapidly developed into a global epidemic. To control its spread, countries have implemented non-pharmaceutical interventions (NPIs), such as school closures, bans of small gatherings, or even stay-at-home orders. Here we study the effectiveness of seven NPIs in reducing the number of new infections, which was inferred from the reported cases of COVID-19 using a semi-mechanistic Bayesian hierarchical model. Based on data from the first epidemic wave of n = 20 countries (i.e., the United States, Canada, Australia, the EU-15 countries, Norway, and Switzerland), we estimate the relative reduction in the number of new infections attributed to each NPI. Among the NPIs considered, bans of large gatherings were most effective, followed by venue and school closures, whereas stay-at-home orders and work-from-home orders were least effective. With this retrospective cross-country analysis, we provide estimates regarding the effectiveness of different NPIs during the first epidemic wave.
Bibliography:Competing Interests: SF reports membership in a COVID-19 working group of the World Health Organization but without competing interest. JPS declares part-time employment at Luciole Medical outside of the submitted work. SF reports grants from the Swiss National Science Foundation outside of the submitted work. All other authors declare no competing interests. All competing interests do not alter our adherence to PLOS ONE policies on sharing data and materials.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0252827